Exelixis
CA · 14 filings, 2025
File · Money Read
What the money shows
Exelixis reported $2M in federal lobbying for 2025 across 14 filings. The filings name 4 lobbying firms, led by Exelixis and Arnold & Porter KAYE Scholer. The filing text lists 5 issue areas.
Sources: Senate LDA · FEC
Lobbying spend · 2025
$2.0M
to shape legislation
About the organization
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Medicare/Medicaid · Taxation/Internal Revenue Code · Copyright/Patent/Trademark · Pharmacy
2Through these firms · 4
EXELIXIS INC.ARNOLD & PORTER KAYE SCHOLER LLPTODD STRATEGY GROUPLMH STRATEGIC SOLUTIONS
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5224A bill to improve training for airport drivers in the movement area at commercial service airports through…